Absci Corporation Common Stock (ABSI)
SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
- Headquarters
- United States
- Employees
- 140
- Market Cap
- $1.4B
About Absci Corporation Common Stock
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process. Its lead product candidate, ABS-201, is an anti-prolactin receptor (PRLR) antibody engineered with an extended half-life to support a patient-friendly dosing interval.
SentiSense also tracks daily options readings for Absci Corporation Common Stock: IV rank, put/call percentile, 25-delta skew, open-interest walls, and unusually active contracts, each measured against the stock's own history. Sign in to view them.
Absci Corporation Common Stock stock analysis, sentiment tracking, and market intelligence on SentiSense.